Andrea Cerutti

PubPeer's vigilance has led to confirmed retractions in early 2026, including two Nature Immunology papers (2001-2002) by Andrea Cerutti and Paolo Casali for image duplication flagged since 2016, a Nature paper from Francis Crick Institute for PhD student data manipulation, and the largest leucovorin-autism trial in European Journal of Pediatrics due to data inconsistencies flagged on PubPeer. New developments feature a Nigerian chemist nearing 35 retractions for image duplication, OSU heart researcher facing remedial training post-misconduct finding with PubPeer involvement, and fresh PubPeer scrutiny on OIST's Paola Laurino across seven papers. Ongoing probes include Taylor & Francis review of COVID vaccine DNA contamination paper and Sonia Melo's lawsuit against MD Anderson; Bishop's Feb 2026 analysis confirms PubPeer preceded 58% of highly-cited retractions (2021-2025). Sholto David's $2.63M settlement against MD Anderson highlights sleuth accountability.

Since early February 2026, new developments include Elsevier's Heliyon retracting 37 additional papers in 2026 amid an ongoing audit uncovering citation stacking and peer review compromise, following Clarivate's hold since 2024. ASTM's Journal of Testing and Evaluation reached 166 retractions by February 12 with enhanced safeguards against compromised peer review. Wolters Kluwer flagged 126 papers in Medicine on February 20 due to suspicious protocols. The International Journal of Obesity retracted a GLP-1 weight loss study on February 23 after statistical review found unsubstantiated claims. These updates affirm improved detection via PubPeer, audits, and editorial scrutiny, with no evidence of escalating fraud.